Comment on "The risk assessment of uveitis after COVID-19 diagnosis"

Patrick Wu¹, Chin-Yuan Yii², Su-Boon Yong^{3

4

5}

Affiliations

¹ College of Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, Florida, USA.
² Division of Gastroenterology and Hepatology, Department of Internal Medicine, Landseed International Hospital, Taoyuan, Taiwan.
³ Department of Allergy and Immunology, China Medical University Children's Hospital, Taichung, Taiwan.
⁴ Department of Medicine, China Medical University, Taichung, Taiwan.
⁵ Center for Allergy, Immunology, and Microbiome (A.I.M.), China Medical University Hospital, Taichung, Taiwan.

Comment

Patrick Wu et al. J Med Virol. 2024 Mar.

. 2024 Mar;96(3):e29494.

doi: 10.1002/jmv.29494.

Patrick Wu¹, Chin-Yuan Yii², Su-Boon Yong^{3

4

5}

¹ College of Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, Florida, USA.
² Division of Gastroenterology and Hepatology, Department of Internal Medicine, Landseed International Hospital, Taoyuan, Taiwan.
³ Department of Allergy and Immunology, China Medical University Children's Hospital, Taichung, Taiwan.
⁴ Department of Medicine, China Medical University, Taichung, Taiwan.
⁵ Center for Allergy, Immunology, and Microbiome (A.I.M.), China Medical University Hospital, Taichung, Taiwan.

No abstract available

Comment in

Reply to comment on "The risk assessment of uveitis after COVID-19 diagnosis by Wu et al. 2024".
Hsu AY, Lin CJ, Hsia NY, Wang YH, Li JX, Chen HS, Wei JC, Tsai YY. Hsu AY, et al. J Med Virol. 2024 May;96(5):e29636. doi: 10.1002/jmv.29636. J Med Virol. 2024. PMID: 38659371 No abstract available.

The risk assessment of uveitis after COVID-19 diagnosis: A multicenter population-based study.
Hsia NY, Hsu AY, Wang YH, Li JX, Chen HS, Wei JC, Lin CJ, Tsai YY. Hsia NY, et al. J Med Virol. 2023 Oct;95(10):e29188. doi: 10.1002/jmv.29188. J Med Virol. 2023. PMID: 37881132